Yahoo
HKSE - Delayed Quote HKD

Shanghai MicroPort MedBot (Group) Co., Ltd. (2252.HK)

21.180 0.000 (0.00%)
At close: August 31 at 4:08:46 PM GMT+8
Chart Range Bar
Loading chart for 2252.HK
  • Previous Close 21.180
  • Open 22.000
  • Bid 21.160 x --
  • Ask 21.160 x --
  • Day's Range 20.520 - 22.000
  • 52 Week Range 19.640 - 35.340
  • Volume 4,624,308
  • Avg. Volume 1,676,681
  • Market Cap (intraday) 21.844B
  • Beta (5Y Monthly) 1.45
  • PE Ratio (TTM) --
  • EPS (TTM) -0.260
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est 36.56

Shanghai MicroPort MedBot (Group) Co., Ltd. engages in the research and development, manufacturing, and sale of surgical robots in the People's Republic of China. The company offers Toumai laparoscopic surgical robot; Toumai single port laparoscopic surgical robot; DFVision 3D electronic laparoscope; SkyWalker orthopedic surgical robot; trans-bronchial surgical robot for natural orifice surgery; R-ONE vascular interventional robot for pan vascular surgery; and iSR'obot Mona Lisa robotic trans perineal prostate biopsy system. It is also involved in the distribution of surgical robot devices. The company was founded in 2014 and is headquartered in Shanghai, China. Shanghai MicroPort MedBot (Group) Co., Ltd. operates as a subsidiary of Shanghai Latent Artificial Intelligence Co., Ltd.

www.medbotsurgical.com

464

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

2252.HK
12.55%
HANG SENG INDEX (^HSI)
9.11%

1-Year Return

2252.HK
22.87%
HANG SENG INDEX (^HSI)
11.37%

3-Year Return

2252.HK
30.74%
HANG SENG INDEX (^HSI)
33.83%

5-Year Return

2252.HK
46.78%
HANG SENG INDEX (^HSI)
8.21%

Analyst Insights

View More

Analyst Price Targets

24.81
36.56 Average
21.180 Current
42.59 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -45.31%

  • Return on Assets (ttm)

    -8.68%

  • Return on Equity (ttm)

    -77.29%

  • Revenue (ttm)

    551.07M

  • Net Income Avi to Common (ttm)

    -249.66M

  • Diluted EPS (ttm)

    -0.260

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    636.32M

  • Total Debt/Equity (mrq)

    102.66%

  • Levered Free Cash Flow (ttm)

    46.48M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: